Cargando…
A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection
BACKGROUND: Colchicine has been used in conditions such as periodic febrile illness, acute pericarditis, and gouty arthritis, all having a common hyperinflammatory response as seen in moderate to severe forms of coronavirus disease 2019 (COVID-19). This project was carried out during the rapid surge...
Autores principales: | Sandhu, Tegveer, Tieng, Arlene, Chilimuri, Sridhar, Franchin, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588830/ https://www.ncbi.nlm.nih.gov/pubmed/33133323 http://dx.doi.org/10.1155/2020/8865954 |
Ejemplares similares
-
Atypical Sjögrenʼs Syndrome Initially Presenting as Lymphocytic Interstitial Pneumonitis followed by Immune Thrombocytopenia
por: Mehmood, Maham, et al.
Publicado: (2021) -
A Rare Case of Concomitant Septic Arthritis, Osteomyelitis, and Pyomyositis Caused by Salmonella
por: Ghazanfar, Haider, et al.
Publicado: (2021) -
Use of Monoclonal Antibodies Therapy for Treatment of Mild to Moderate COVID-19 in 4 Patients with Rheumatologic Disorders
por: Franchin, Giovanni, et al.
Publicado: (2021) -
Randomized controlled trial of colchicine add on to the standard therapy in moderate and severe corona virus Disease-19 infection
por: Gorial, Faiq I., et al.
Publicado: (2022) -
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publicado: (2021)